摘要
目的探讨胃癌中Musashi-2的表达及其临床意义。方法采用免疫组化法检测50例胃癌组织及20例非萎缩性胃炎组织(对照组)中Musashi-2的表达情况,分析胃癌组Musashi-2蛋白的表达与临床病理参数的关系。分析其表达水平与年龄、肿瘤大小、淋巴结转移、分化程度及术后生存时间的相关性。结果胃癌组Musashi-2蛋白的阳性表达率是64.0%(32/50),对照组是25.0%(5/20),胃癌组高于对照组(χ2=4.850,P<0.05)。组织分化程度越低、TNM分期越高,Musahi-2蛋白的阳性表达率越高(P<0.05)。生存结局与年龄、淋巴结转移、病理分化程度、Musashi-2表达相关。结论 Musashi-2可能与胃癌的发生发展、预后有关,可将其做为胃癌干细胞标志物深入研究。
Objective To investigate the expression of Musashi-2 in gastric carcinoma and the correlation with the occurrence and development of gastric carcinoma. Methods The expression of Musashi-2 protein was detected by immunohistochemical method in 50 gastric carcinoma samples and 20 non atrophic gastritis samples(control). The relationship between Musashi-2 protein expression and clinical pathological parameters was analyzed. The relationship between the expression of Musashi-2 and patients' age, tumor size, lymph node metastasis, tumor differentiation, clinical stages and prognosis was analyzed. Results The positive expression rates of Musashi-2 in gastric carcinoma samples and non atrophic gastritis samples were 64.0% (32/50) and 25.0% (5/20), which showed higher expression rates in gastric carcinoma group than that in control group (Х^2= 4. 850, P d0.05). There were significant differences in the expressions of Musashi-2 proteins between different histological stages and TNM staging ( P 〈0.05). The positive expression of Musashi-2 protein increased as the degree of differentiation decreased and TNM stage increased. The overall survival rates were correlated with age, lymph node metastasis, tumor differentiation and the expression of Musashi-2. Conclusion The expression of Musashi-2 may be related with the initiation, development and prognosis of gastric cancer, which can be used as the stem cell markers of gastric carcinoma for further study.
出处
《临床荟萃》
CAS
2015年第3期246-249,共4页
Clinical Focus